J&J expects more than $3 billion in Covid vaccine sales this year in mixed quarterly report
J&J's revenue of $24.8 billion rose 10.4%, mostly driven by $1.82 billion in international sales of its Covid vaccine.
J&J's revenue of $24.8 billion rose 10.4%, mostly driven by $1.82 billion in international sales of its Covid vaccine.
IBM's revenue growth accelerated, and the company's net income jumped in the quarter after the spinout of a major part of its business.
Fed officials are set to keep interest rates near zero, while likely signaling preparation to raise short-term interest rates at their following gathering in mid-March.
Investors who think they can both save the world and make a profit need to get back to basics, our columnist writes. This is the...
Federal regulators proposed measures that would significantly increase their visibility into private-equity funds and some hedge funds, the first in a range of plans to...
At the top: Consumer payments and “fractionalization.” But that’s just the beginning.
Tesla will report earnings after the close; Texas Instruments posted an earnings beat.
They are taking advantage of their size and low costs. But can they stay a step ahead for long?
Zillow’s near-term fate hinges upon a delicate market balance the likes of which we’ve never quite seen.